Today: 7 February 2026
Subscribe

PennyMac Financial Services stock slides again as KBW cuts target and MSR runoff stays in focus

PennyMac Financial Services stock slides again as KBW cuts target and MSR runoff stays in focus

PennyMac Financial (PFSI) fell 5.3% to $94.58 Monday after KBW cut its price target to $115 from $143, citing concerns over faster mortgage prepayments and servicing rights runoff. The stock has dropped 38% since Jan. 29. Fourth-quarter net income was $106.8 million, with servicing segment pretax income plunging to $37.3 million. A law firm has launched a probe into the late-January share plunge.
2 February 2026
·
Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus

Pfizer stock (PFE) edges up ahead of Feb. 3 earnings as obesity pricing shifts and RSV dispute draw focus

Pfizer shares rose 0.3% to $26.51 ahead of fourth-quarter and full-year 2025 results due Feb. 3. Analysts expect adjusted earnings of 57–58 cents per share on $16.7–16.9 billion revenue. Obesity drug price cuts and a UK ruling against Sanofi in an RSV dispute add pressure. Pfizer projects 2026 revenue of $59.5–62.5 billion, factoring in losses from COVID-19 products and patent expirations.
2 February 2026
·
Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent shares jumped over 6% Monday, trading as high as $229.10 after Bystronic confirmed it completed the purchase of Coherent’s Tools for Materials Processing business. The company will report fiscal second-quarter results after markets close Feb. 4. Analysts expect earnings of $1.22 per share on $1.6 billion in revenue. Intraday volatility spiked ahead of the results, with options pricing in a 15% move by Feb. 6.
2 February 2026
··
Boston Scientific stock price drops today: BSX slides as investors size up Feb. 4 earnings, Watchman trial date

Boston Scientific stock price drops today: BSX slides as investors size up Feb. 4 earnings, Watchman trial date

Boston Scientific shares fell 1.6% to $92.01 Monday, lagging sector peers as the S&P 500 rose. Investors are watching for the company’s Feb. 4 earnings call and the March 28 release of CHAMPION-AF trial results for its Watchman device. TD Cowen maintained a buy rating, citing potential upside if the trial data proves positive.
2 February 2026
··
VSE Corporation stock dives as $1 billion share-and-unit sale spooks investors

VSE Corporation stock dives as $1 billion share-and-unit sale spooks investors

VSE Corporation shares fell 10.4% to $195.93 after announcing a $1 billion stock-and-unit offering to fund its acquisition of Precision Aviation Group. The company detailed a plan to raise $650 million in common stock and $350 million in tangible equity units, with additional debt financing. SEC filings show PAG posted $472 million in 2024 revenue and $6.8 million net income. Traders focused on dilution risk as the offering terms emerged.
2 February 2026
·
Goldman Sachs stock climbs as Fed chair nominee Warsh and strong factory data steady banks

Goldman Sachs stock climbs as Fed chair nominee Warsh and strong factory data steady banks

Goldman Sachs shares rose 1.3% to $947.36 Monday afternoon as U.S. banks rallied and the S&P 500 neared record highs. The ISM’s manufacturing index hit 52.6 in January, its first expansion in a year. The U.S. jobs report, scheduled for Friday, was delayed due to a partial government shutdown. Lawmakers began debating a bill to end the shutdown, with a House vote set for Tuesday.
2 February 2026
····
Amphenol stock rebounds in New York trade as APH swings again — here’s what matters now

Amphenol stock rebounds in New York trade as APH swings again — here’s what matters now

Amphenol shares rose 1.2% to $145.85 Monday after swinging between $141.02 and $148.36, rebounding from last week’s 3.7% drop. The move followed record quarterly results and a $6.4 billion sales report, but the stock remains 13.8% below its Jan. 27 high. Wall Street’s broader rally lifted sector peers TE Connectivity and Eaton. Amphenol’s forecast includes $900 million in sales from its recent CCS acquisition.
2 February 2026
··
Rocket Lab stock slides again as RKLB pulls back from January highs

Rocket Lab stock slides again as RKLB pulls back from January highs

Rocket Lab shares fell 5.35% to $75.79 by Monday afternoon, extending losses to 24% below their January high. The drop follows reports that Congress pulled funding for NASA’s Mars Sample Return mission, for which Rocket Lab had proposed a $4 billion role. Investors remain focused on the company’s dependence on government contracts and delays in its Neutron rocket program. Rocket Lab will report Q4 and full-year results on Feb. 26.
2 February 2026
···
Eldorado Gold stock sinks on Foran Mining buyout: what investors watch next

Eldorado Gold stock sinks on Foran Mining buyout: what investors watch next

Eldorado Gold shares fell about 9% Monday after announcing a deal to acquire Foran Mining, expanding its copper portfolio. The stock dropped $4.03 to $38.89 in New York trading. Foran shareholders will receive 0.1128 Eldorado shares plus C$0.01 per share, with the merger expected to close in Q2 pending approvals. Eldorado reports full-year earnings Feb. 19.
2 February 2026
······
Bank of America stock rises as yields firm — here’s what could move BAC next

Bank of America stock rises as yields firm — here’s what could move BAC next

New York, February 2, 2026, 14:57 EST — Regular session Bank of America shares climbed roughly 1.4% to $53.94 in afternoon trading on the New York Stock Exchange Monday, bouncing back after an early slide. The stock gained around 74 cents from Friday’s $53.20 close, fluctuating between $52.99 and $54.08. Roughly 19.5 million shares traded hands. The stock’s move followed a broader shift in rates after Donald Trump nominated Kevin Warsh to head the Federal Reserve. The 10-year Treasury yield climbed about 0.03 percentage point to 4.271%. Traders also braced for policy decisions this week from the European Central Bank,
2 February 2026
··
1 … 85 86 87 88 89 … 1,632

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop